Literature DB >> 21742098

Practice variability and outcomes of coil embolization of aortopulmonary collaterals before Fontan completion: a report from the Pediatric Heart Network Fontan Cross-Sectional Study.

Puja Banka1, Lynn A Sleeper, Andrew M Atz, Collin G Cowley, Dianne Gallagher, Matthew J Gillespie, Eric M Graham, Renee Margossian, Brian W McCrindle, Charlie J Sang, Ismee A Williams, Jane W Newburger.   

Abstract

BACKGROUND: The practice of coiling aortopulmonary collaterals (APCs) before Fontan completion is controversial, and published data are limited. We sought to compare outcomes in subjects with and without pre-Fontan coil embolization of APCs using the Pediatric Heart Network Fontan Cross-Sectional Study database which enrolled survivors of prior Fontan palliation.
METHODS: We compared hospital length of stay after Fontan in 80 subjects who underwent APC coiling with 459 subjects who did not. Secondary outcomes included post-Fontan complications and assessment of health status and ventricular performance at cross-sectional evaluation (mean 8.6 ± 3.4 years after Fontan).
RESULTS: Centers varied markedly in frequency of pre-Fontan APC coiling (range 0%-30% of subjects, P < .001). The coil group was older at Fontan (P = .004) and more likely to have single right ventricular morphology (P = .054) and pre-Fontan atrioventricular valve regurgitation (P = .03). The coil group underwent Fontan surgery more recently (P < .001), was more likely to have a prior superior cavopulmonary anastomosis (P < .001), and more likely to undergo extracardiac Fontan connection (P < .001) and surgical fenestration (P < .001). In multivariable analyses, APC coiling was not associated with length of stay (hazard ratio for remaining in-hospital 0.91, 95% CI 0.70-1.18, P = .48) or postoperative complications, except more post-Fontan catheter interventions (hazard ratio 1.74, 95% CI 1.04-2.91, P = .03), primarily additional APC coils. The groups had similar outcomes at cross-sectional evaluation.
CONCLUSION: Management of APCs before Fontan shows marked practice variation. We did not find an association between pre-Fontan coiling of APCs and shorter postoperative hospital stay or with better late outcomes. Prospective studies of this practice are needed.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21742098      PMCID: PMC3137245          DOI: 10.1016/j.ahj.2011.03.021

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  19 in total

1.  Incidence and implications of systemic to pulmonary collaterals after bidirectional cavopulmonary anastomosis.

Authors:  D B McElhinney; V M Reddy; W Tworetzky; E Petrossian; F L Hanley; P Moore
Journal:  Ann Thorac Surg       Date:  2000-04       Impact factor: 4.330

2.  Radiation exposure to children during cardiac catheterization.

Authors:  A Boothroyd; E McDonald; B M Moores; V Sluming; H Carty
Journal:  Br J Radiol       Date:  1997-02       Impact factor: 3.039

3.  Management of aortopulmonary collateral arteries in Fontan patients: occlusion improves clinical outcome.

Authors:  Kirk R Kanter; Robert N Vincent
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2002

4.  Aortopulmonary collateral flow in the Fontan patient: does it matter?

Authors:  S M Bradley; M M McCall; J J Sistino; W A Radtke
Journal:  Ann Thorac Surg       Date:  2001-08       Impact factor: 4.330

5.  Lessons we have learned from our children: cancer risks from diagnostic radiology.

Authors:  Eric J Hall
Journal:  Pediatr Radiol       Date:  2002-07-19

6.  Aortopulmonary collateral vessels and prolonged pleural effusions after modified Fontan procedures.

Authors:  R L Spicer; K C Uzark; J W Moore; R D Mainwaring; J J Lamberti
Journal:  Am Heart J       Date:  1996-06       Impact factor: 4.749

7.  Complications associated with pediatric cardiac catheterization.

Authors:  R Vitiello; B W McCrindle; D Nykanen; R M Freedom; L N Benson
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

8.  Clinical outcomes and utility of cardiac catheterization prior to superior cavopulmonary anastomosis.

Authors:  David W Brown; Kimberlee Gauvreau; Adrian M Moran; Kathy J Jenkins; Stanton B Perry; Pedro J del Nido; Steven D Colan
Journal:  J Thorac Cardiovasc Surg       Date:  2003-07       Impact factor: 5.209

9.  Extent of aortopulmonary collateral blood flow as a risk factor for Fontan operations.

Authors:  H Ichikawa; T Yagihara; H Kishimoto; F Isobe; F Yamamoto; K Nishigaki; O Matsuki; T Fujita
Journal:  Ann Thorac Surg       Date:  1995-02       Impact factor: 4.330

10.  Prevalence and risk factors for aortopulmonary collateral vessels after Fontan and bidirectional Glenn procedures.

Authors:  J K Triedman; N D Bridges; J E Mayer; J E Lock
Journal:  J Am Coll Cardiol       Date:  1993-07       Impact factor: 24.094

View more
  13 in total

1.  Interventions after Norwood procedure: comparison of Sano and modified Blalock-Taussig shunt.

Authors:  Julia Fischbach; Nicodème Sinzobahamvya; Christoph Haun; Ehrenfried Schindler; Peter Zartner; Martin Schneider; Viktor Hraška; Boulos Asfour; Joachim Photiadis
Journal:  Pediatr Cardiol       Date:  2012-06-04       Impact factor: 1.655

2.  Coronary artery bypass grafting in single-ventricle patients palliated with Fontan procedure: future consideration.

Authors:  Sawsan Awad; Khaled Abdelhady
Journal:  Pediatr Cardiol       Date:  2014-12-16       Impact factor: 1.655

3.  Frequency of Mammary Artery Coiling in Single-Ventricle Patients and Future Coronary Artery Grafting.

Authors:  Khaled Abdelhady; Anas Taqatqa; Carlos Miranda; Sawsan Awad
Journal:  Pediatr Cardiol       Date:  2016-06-15       Impact factor: 1.655

4.  Variations in Practice Patterns and Consistency With Published Guidelines for Balloon Aortic and Pulmonary Valvuloplasty: An Analysis of Data From the IMPACT Registry.

Authors:  Andrew C Glatz; Kevin F Kennedy; Jonathan J Rome; Michael L O'Byrne
Journal:  JACC Cardiovasc Interv       Date:  2018-03-26       Impact factor: 11.195

5.  Relation of systemic-to-pulmonary artery collateral flow in single ventricle physiology to palliative stage and clinical status.

Authors:  Ashwin Prakash; Rahul H Rathod; Andrew J Powell; Doff B McElhinney; Puja Banka; Tal Geva
Journal:  Am J Cardiol       Date:  2012-01-03       Impact factor: 2.778

6.  Routine Cardiac Catheterization Prior to Fontan Operation: Is It a Necessity?

Authors:  Bassel Mohammad Nijres; Joshua J Murphy; Karim Diab; Sawsan Awad; Ra-Id Abdulla
Journal:  Pediatr Cardiol       Date:  2018-02-03       Impact factor: 1.655

7.  Durable Benefit of Particle Occlusion of Systemic to Pulmonary Collaterals in Select Patients After Superior Cavopulmonary Connection.

Authors:  Michael L O'Byrne; David N Schidlow
Journal:  Pediatr Cardiol       Date:  2017-10-07       Impact factor: 1.655

8.  Determination of the Frequency of Right and Left Internal Mammary Artery Embolization in Single Ventricle Patients: A Two-Center Study.

Authors:  Bassel Mohammad Nijres; Anas S Taqatqa; Lamya Mubayed; Gregory J Jutzy; Ra-Id Abdulla; Karim A Diab; Hoang H Nguyen; Brieann A Muller; Cyndi R Sosnowski; Joshua J Murphy; Joseph Vettukattil; Vishal R Kaley; Darcy N Marckini; Bennett P Samuel; Khaled Abdelhady; Sawsan Awad
Journal:  Pediatr Cardiol       Date:  2018-08-13       Impact factor: 1.655

9.  Percutaneous interventions in Fontan circulation.

Authors:  Eduardo Franco; Enrique José Balbacid Domingo; Viviana Arreo Del Val; Luis Garcia Guereta Silva; María Jesús Del Cerro Marín; Aurora Fernández Ruiz; Fernando Villagrá; Federico Gutiérrez-Larraya Aguado
Journal:  Int J Cardiol Heart Vasc       Date:  2015-06-23

10.  Aortopulmonary collateral flow is related to pulmonary artery size and affects ventricular dimensions in patients after the fontan procedure.

Authors:  Heiner Latus; Kerstin Gummel; Tristan Diederichs; Anna Bauer; Stefan Rupp; Gunter Kerst; Christian Jux; Hakan Akintuerk; Dietmar Schranz; Christian Apitz
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.